[144] Cardlytics, Inc. SEC Filing

Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) disclosure shows a proposed insider sale of 7,799 common shares through Fidelity Brokerage Services on 10/02/2025 with an aggregate market value of $17,710.75. The shares were acquired on 10/01/2025 upon restricted stock vesting and were granted as compensation. The filing lists total common shares outstanding as 53,236,901. The filer also reported three sales by Amit Gupta in the prior three months: 6,725 shares on 07/02/2025 (gross proceeds $11,987.99), 68,260 shares on 08/18/2025 (gross proceeds $76,806.15), and 68,685 shares on 08/19/2025 (gross proceeds $76,803.57), totaling 143,670 shares and $165,597.71 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Restricted stock vesting clearly disclosed: 7,799 shares acquired 10/01/2025 as compensation
• Proposed sale notice filed as LIVE and names the executing broker Fidelity Brokerage Services
• Filer attests there is no undisclosed material adverse information in the issuer

Negative

• Substantial insider selling in prior three months: 143,670 shares sold by Amit Gupta
• Prior three-month gross proceeds total $165,597.71, indicating meaningful insider liquidity

Insights

Corporate Governance Analyst

Insider sale filed for 7,799 vested shares; prior three-month sales totaled 143,670 shares.

The filing documents a proposed market sale on 10/02/2025 of shares acquired through restricted stock vesting on 10/01/2025, indicating these shares were granted as compensation. The seller also disclosed three prior sales by Amit Gupta totaling 143,670 shares for $165,597.71 gross proceeds during July–August 2025.

This record provides transparent compliance with Rule 144 reporting requirements and names Fidelity Brokerage Services as the executing broker.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7799	17710.75	53236901	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Vesting	Issuer			7799	10/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Amit Gupta 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	07/02/2025	6725	11987.99
Amit Gupta 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	08/18/2025	68260	76806.15
Amit Gupta 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	08/19/2025	68685	76803.57

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Cardlytics (CDLX) report?

It reports a proposed sale of 7,799 common shares on 10/02/2025 via Fidelity, acquired by restricted stock vesting on 10/01/2025 as compensation.

Who sold shares in the past three months according to the filing?

Amit Gupta sold 6,725 shares on 07/02/2025, 68,260 on 08/18/2025, and 68,685 on 08/19/2025.

How many total shares were outstanding per the filing?

The filing lists 53,236,901 common shares outstanding.

What were the gross proceeds from the prior three-month insider sales?

The three listed sales generated combined gross proceeds of $165,597.71.

Were the proposed shares acquired via purchase or compensation?

The 7,799 shares were acquired on 10/01/2025 through restricted stock vesting and paid as compensation.

Which broker is named for the proposed sale?

The executing broker is Fidelity Brokerage Services LLC at the address provided in the filing.